Company / EPS (Diluted)
CONMED Corporation EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.04
FY2025
5-year range
-$2.68 / $2.04
FY2021-FY2025
Trend
+176.1%
vs FY2024
Sector context
#54 of 159
Health Care
What the data says
At $2.04, CONMED Corporation's eps (diluted) ranks #54 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-2.68 in FY2024 to $2.04 in FY2025.
Based on SEC 10-K filings.
2.04 in FY2025 with a 5-year CAGR of +7.7%.
Improved from $1.94 to $2.04 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +85.4%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
#54 of 159 in Health CareTop 34% of 159This company $2.04 Sector average $1.56
▼
+31.0% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 176.1% year-over-year.
- Ranks #54 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.04 | +176.1% |
| FY2024 | -$2.68 | -238.1% |
| FY2023 | $1.94 | +506.2% |
| FY2022 | $0.32 | -67.0% |
| FY2021 | $0.97 | -31.2% |
| FY2020 | $1.41 | -28.4% |
| FY2019 | $1.97 | +278.8% |
| FY2018 | $0.52 | -52.3% |
| FY2017 | $1.09 | -6.0% |
| FY2016 | $1.16 | -9.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026